THE Italy has held talks with pharmaceutical companies to begin production of messenger RNA (mRNA) vaccines in the country, the Financial Times reports.
Rome discussed domestic production of vaccines based on mRNA with Moderna Inc, the Swiss Novartis AG and the Italian ReiThera, is added to the British newspaper article, which cites people who know the case, as reported by Reuters and the Athens News Agency.
It is noted that A recent Politico article reported that the EU is essentially taking sides on the vaccine issue, clearly showing its preference for mRNA technology.
The new doses of the vaccine, which will be distributed between 2021 and 2023, are expected to help the EU if enhanced vaccines are needed to fight coronavirus mutations, Ursula von der Leyen said.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
